He Jie Tang in the treatment of chronic hepatitis B patients

Table 1 Levels of ALT, AST, TB, and HBV-DNA before and after the treatment (mean±SD)

		n	ALT (U/L)	AST (U/L)	TB (μmol/L)	HBV-DNA (copy/mL)
Group III		20	21.52±8.90	15.56±7.65	11.75±5.71	<1 000
Group I	Pre-T	50	232.52±12.25	139.65±9.62	43.35±5.86	(1.62±0.81)×108.31
	Post-T	50	33.26±9.35b	35.18±8.26b	19.95±5.12b	(9.25±1.90)×105.02a
Group II	Pre-T	35	225.70±11.61	135.45±9.21	41.45±5.85	(1.47±0.65)×108.22
Post-T		35	30.86±8.95b	65.68±8.82b	29.55±546b	(8.26±2.20)×107.62

Pre-T: before treatment; Post-T: after treatment; ^aP＜0.05 vs before treatment in the same group;

^bP＜0.01 vs before treatment in the same group.